Company profile: Sigilon Therapeutics
1.1 - Company Overview
Company description
- Provider of immune-privileged, immune-protected engineered human cell products to treat acute and chronic diseases by restoring normal physiology while aiming to avoid fibrosis and immune rejection.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sigilon Therapeutics
HighTide Therapeutics
HQ: China
Website
- Description: Provider of global clinical-stage biopharmaceutical drug development, centered on HTD1801, a candidate targeting NASH, type 2 diabetes (T2DM), severe hypertriglyceridemia (SHTG), primary sclerosing cholangitis (PSC), and primary biliary cholangitis (PBC). Conducts multi-regional clinical trials, including a Phase 2b study for NASH and a Phase 3 study for T2DM.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HighTide Therapeutics company profile →
Inversago Pharma
HQ: Canada
Website
- Description: Provider of clinical-stage biotech therapies based on peripherally-acting CB1 inverse agonists, including INV-202, a small molecule CB1 receptor blocker for metabolic disorders in Phase 2 studies for diabetic kidney disease and obesity, and INV-347, a next-generation oral CB1 receptor blocker in Phase 1 evaluating safety, tolerability, and pharmacokinetics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inversago Pharma company profile →
Keryx Biopharmaceuticals
HQ: United States
Website
- Description: Provider of innovative biopharmaceutical medicines, focused on their development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Keryx Biopharmaceuticals company profile →
BarioSurg
HQ: United States
Website
- Description: Provider of a proprietary, long-term, minimally invasive and reversible medical device, the Gastric Vest System, for bariatric surgeons to address obesity and metabolic disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BarioSurg company profile →
ViaCyte
HQ: United States
Website
- Description: Provider of preclinical regenerative medicine therapies for diabetes, based on differentiation of stem cells into pancreatic beta-cell precursors implanted subcutaneously in an encapsulation device.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ViaCyte company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sigilon Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sigilon Therapeutics
2.2 - Growth funds investing in similar companies to Sigilon Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sigilon Therapeutics
4.2 - Public trading comparable groups for Sigilon Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →